Objective To investigate the efficacy and safety of CHOP and FCD programmes in the treatment of newly diagnosed indolent lymphoma. Method A total of 50 patients with initial treatment of indolent lymphoma in Xinhui People's Hospital from April 2012 to April 2015 were retrospectively analyzed. They were divided into two groups of 25 patients each. CHOP group were treated with combined chemotherapy of cyclophosphamide, doxorubicin, vincristine and prednisone. FCD group were treated with combined chemotherapy ...